TVTX

TVTX Operating Expenses

$598.71MTTM · USD

Period ending:

TVTX FY Operating ExpensesUSD
TVTX FY Operating Expenses2009-02-28: $13.43K2012-02-29: $12.83K2012-12-31: $30.26M2013-12-31: $23.97M2014-12-31: $107.44M2015-12-31: $129.97M2016-12-31: $168.87M2017-12-31: $182.13M2018-12-31: $227.41M2019-12-31: $269.91M2020-12-31: $368.36M2021-12-31: $327.44M2022-12-31: $424.85M2023-12-31: $521.93M2024-12-31: $549.26M2025-12-31: $543.21M$549.26M$0.00
2009-02-282025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

TVTX operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 16 observations from Feb 28, 2009 to Dec 31, 2025.

Travere Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
543,213,000
549,258,000
521,926,000
424,853,000
327,443,000
368,358,000
269,914,000
227,411,000
182,126,000
168,868,000
129,967,000
107,439,919
23,972,073
30,257,017
12,825
13,432

Compare operating expenses

All TVTX financial metrics · TVTX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.